Evidence mapPaperPMID 41909491Full record

ArticleAmerican heart journal plus : cardiology research and practice2026

Multiethnic community cardio-metabolic risk factor screening in Northeast Florida: The VIDASANA Project.

Gladys Velarde, Katia Bravo-Jaimes, Grishma Sharma, Maedeh Ganji, Carmen Smotherman, Catherine Klein, Khadeeja Esmail, Jose Rivas

Abstract read
In one paragraph

Article in American heart journal plus : cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gladys VelardeDivision of Cardiology, University of Florida, Jacksonville, FL, United States of America.
Katia Bravo-JaimesDepartment of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States of America.
Grishma SharmaDepartment of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States of America.
Maedeh GanjiDivision of Cardiology, University of Florida, Jacksonville, FL, United States of America.
Carmen SmothermanDepartment of Pathology and Laboratory Medicine, University of Florida College of Medicine-Jacksonville, United States of America.
Catherine KleinDivision of Cardiology, University of Florida, Jacksonville, FL, United States of America.
Khadeeja EsmailDivision of Cardiology, University of Florida, Jacksonville, FL, United States of America.
Jose RivasDivision of Cardiology, University of Florida, Jacksonville, FL, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiometabolic risk disproportionately affects racially and ethnically diverse United States populations. Few community-based studies have examined the intersection of metabolic syndrome (MS), functional capacity, and cardiovascular disease (CVD) risk across multiple groups within a single region. Objective: To evaluate MS prevalence, functional capacity, and 10-year CVD risk in adults from diverse communities in Northeast Florida. Methods: A total of 345 adults were screened between 2017 and 2019 in a community-based, cross-sectional study. MS was defined by Adult Treatment Panel III criteria (≥3 of 5 thresholds). Functional capacity and 10-year CVD risk were assessed using Duke Activity Status Index (DASI), and Framingham Risk Score (FRS). Group differences were evaluated using appropriate univariate tests, and multivariable logistic regression identified independent predictors of MS ( Results: MS prevalence was highest among Hispanic (H) subjects (47%), followed by non-Hispanic Black (NHB, 35%) and Southeast Asian participants (SEA, 33%). Adjusted odds of MS were higher in H (OR 7.3, 95% CI 1.8-28.6) and SEA participants (OR 5.2, 95% CI 1.2-22.2) compared to non-Hispanic White (NHW) subjects. DASI scores were significantly lower in women and minority (H and SEA) populations. MS further reduced functional capacity in H ( Conclusions: This study identified marked disparities in MS prevalence, functional capacity, and cardiovascular risk across racial and ethnic groups with greater burden among minoritized populations across all domains. Findings support the need for more inclusive, culturally informed prevention strategies for diverse populations.

Indexed as

Cardiovascular riskCommunity-based screeningDuke activity status indexFramingham risk scoreHealth disparitiesMetabolic syndromeMinority health

Identifiers

PMID41909491
PMCPMC13019604

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.